ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,487.03
0.25%
Dow Jones
38,834.86
0.15%
US Dollar vs MXN
18.41579
-0.10%
Brent Oil
84.685
-0.01%
Bitcoin
66,082.44
1.72%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Cytek Biosciences Inc (CTKB)

  7. Cytek Biosciences Inc (CTKB) Noticias

CTKB Cytek Biosciences Inc

5.61
0.00 (0.00%)
Pre Mercado
Última actualización: 03:00:31
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cytek Biosciences Inc CTKB NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 5.61 03:00:31
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.61
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
11/6/202415:02EDGAR2Form 8-K - Current report
07/6/202418:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202417:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/6/202407:00GLOBECytek Biosciences Announces $50 Million Stock Repurchase..
31/5/202415:48EDGAR2Form SD - Specialized disclosure report
30/5/202415:05GLOBECytek Biosciences to participate at the Goldman Sachs 45th..
28/5/202416:30GLOBE1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek®..
22/5/202417:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202417:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202417:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202417:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/5/202416:30GLOBECytek® Biosciences Adds Ability to Detect Subcellular..
08/5/202415:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202415:20EDGAR2Form 8-K - Current report
08/5/202415:05GLOBECytek Biosciences Reports First Quarter 2024 Financial..
30/4/202416:30GLOBECytek® Biosciences to Spotlight Cell Analysis Solutions at..
29/4/202408:00GLOBECytek Biosciences to Report First Quarter 2024 Financial..
19/3/202407:00GLOBECytek® Biosciences Names William McCombe Chief Financial..
08/3/202417:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202417:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202417:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202417:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202417:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202416:30GLOBECytek® Biosciences Opens New Facility to Address Increasing..
01/3/202405:06EDGAR2Form 8-K - Current report
28/2/202416:05GLOBECytek Biosciences Reports Fourth Quarter and Full Year 2023..
27/2/202405:06EDGAR2Form 8-K - Current report
22/2/202416:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202415:07EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202415:10GLOBECytek Biosciences to Participate in Upcoming Investor..
07/2/202415:05GLOBECytek Biosciences to Report Fourth Quarter and Full Year..
17/1/202416:30GLOBECytek® Biosciences Signs Agreement with CRG and UPF to..
09/1/202405:05EDGAR2Form 8-K - Current report
08/1/202408:00GLOBECytek Biosciences Announces Preliminary Full Year 2023..
28/12/202315:05GLOBECytek Biosciences to present at the 42nd Annual J.P. Morgan..
27/12/202316:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:00GLOBECytek® Biosciences Introduces the Cytek Orion™ Reagent..
19/12/202315:28EDGAR2Form 144 - Report of proposed sale of securities
28/11/202306:00EDGAR2Form 8-K - Current report
27/11/202319:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202319:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202316:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
CTKB
Cytek Biosciences
COIN
SLGBTC
COIN
EMBUSD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados